TREM2 and early-onset autosomal dominant Alzheimer disease: Whereas understudied in PDA, TREM2 has been extensively evaluated in Alzheimer’s disease, a neurodegenerative disease, which, like cancer, is marked by a chronic inflammatory response (Kinney et al, 2018).